---
title: "《盈警》寰宇娱乐文化预告全年亏损至少扩至 5,700 万元"
description: "寰宇娱乐文化发盈警，预计 6 月止财政年度亏损介乎 5,700 万至 6,700 万元，相较上年度录得 3,120 万元。亏损增加主要因电影版权、制作中电影及电影相关按金之收入减少而作出减值亏损增加约 4,690 万元。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/248273398.md"
published_at: "2025-07-13T05:17:58.000Z"
---

# 《盈警》寰宇娱乐文化预告全年亏损至少扩至 5,700 万元

> 寰宇娱乐文化发盈警，预计 6 月止财政年度亏损介乎 5,700 万至 6,700 万元，相较上年度录得 3,120 万元。亏损增加主要因电影版权、制作中电影及电影相关按金之收入减少而作出减值亏损增加约 4,690 万元。

寰宇娱乐文化 (01046.HK) 发盈警，预计 6 月止财政年度亏损介乎 5,700 万至 6,700 万元，相较上年度录得 3,120 万元。亏损增加主要因电影版权、制作中电影及电影相关按金之收入减少而作出减值亏损增加约 4,690 万元。

### Related Stocks

- [01046.HK - 寰宇娱乐文化](https://longbridge.com/zh-CN/quote/01046.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/zh-CN/news/276024005.md) |
| Branded Entertainment Executives Anthony Damianakis, Pete Fergusson Launch Dubai-Based Startup IPX to Connect Brands With Content (EXCLUSIVE) | Branded entertainment executives Anthony Damianakis and Pete Fergusson are launching a startup called IPX in Dubai, with | [Link](https://longbridge.com/zh-CN/news/276046845.md) |
| Beijing Haizhi Technology Announces Final Offer Price | Beijing Haizhi Technology Group Co Ltd:FINAL OFFER PRICE HK$27.06 PER H SHARE UNDER GLOBAL OFFERING | [Link](https://longbridge.com/zh-CN/news/275780031.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-CN/news/276056763.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。